
Nukkleus (NUKKW) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
0
Gross Profit
0
Operating Income
-1.5M
Net Income
103.0M
Balance Sheet Metrics
Total Assets
8.6M
Total Liabilities
65.8M
Shareholders Equity
-57.2M
Cash Flow Metrics
Operating Cash Flow
103.4M
Free Cash Flow
-1.4M
Revenue & Profitability Trend
Nukkleus Income Statement From 2019 to 2024
Metric | 2024 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 5.9M | 21.5M | 19.3M | 19.2M | 19.2M |
Cost of Goods Sold | 4.9M | 22.2M | 19.4M | 18.9M | 18.9M |
Gross Profit | 998.5K | -661.4K | -82.3K | 300.0K | 300.0K |
Gross Margin % | 16.9% | -3.1% | -0.4% | 1.6% | 1.6% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 8.6M | 5.9M | 850.1K | 413.1K | 1.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 8.6M | 5.9M | 850.1K | 413.1K | 1.0M |
Operating Income | -7.6M | -6.8M | -932.4K | -113.1K | -715.8K |
Operating Margin % | -129.3% | -31.7% | -4.8% | -0.6% | -3.7% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 550.1K | 0 | 4.2K | 6.0K | 6.0K |
Other Non-Operating Income | -322.7K | -5.0M | -272 | 18.6K | -8.3K |
Pre-tax Income | -8.5M | -11.8M | -936.8K | -100.6K | -730.1K |
Income Tax | - | 0 | 0 | 0 | 0 |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -8.5M | -11.8M | -936.8K | -100.6K | -730.1K |
Net Margin % | -144.1% | -55.1% | -4.9% | -0.5% | -3.8% |
Key Metrics | |||||
EBITDA | -7.6M | -4.8M | -463.4K | -113.1K | -715.8K |
EPS (Basic) | - | $-0.03 | $0.00 | $0.00 | $0.00 |
EPS (Diluted) | - | $-0.03 | $0.00 | $0.00 | $0.00 |
Basic Shares Outstanding | - | 356133960 | 257771553 | 230485100 | 230485100 |
Diluted Shares Outstanding | - | 356133960 | 257771553 | 230485100 | 230485100 |
Income Statement Trend
Nukkleus Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 3.7K | - | 364.0K | 403.8K | 82.8K |
Short-term Investments | 615.4K | - | 248.2K | 1.2M | 12 |
Accounts Receivable | - | - | 0 | 58.0K | 0 |
Inventory | - | - | - | - | - |
Other Current Assets | 3.1K | - | 89.0K | 13.1K | - |
Total Current Assets | 965.7K | - | 3.7M | 5.1M | 3.8M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | 19.3K | - | 8.1M | 10.8M | 0 |
Intangible Assets | 19.3K | - | 8.1M | 10.8M | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | 19.3K | - | 14.7M | 10.8M | 0 |
Total Assets | 985.0K | - | 18.4M | 15.8M | 3.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 448.3K | - | 51.7K | 54.8K | 0 |
Short-term Debt | 3.0M | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 851.2K | - | 2.3M | 2.0M | 248.5K |
Total Current Liabilities | 7.1M | - | 7.5M | 6.7M | 5.2M |
Non-Current Liabilities | |||||
Long-term Debt | 966.1K | - | - | - | - |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 1.0M | - | 0 | 0 | 0 |
Total Liabilities | 8.1M | - | 7.5M | 6.7M | 5.2M |
Equity | |||||
Common Stock | 209 | 126 | 1.0K | 33.2K | 23.0K |
Retained Earnings | -40.3M | - | -14.3M | -2.5M | -1.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | -7.1M | - | 10.9M | 9.2M | -1.4M |
Key Metrics | |||||
Total Debt | 4.0M | 0 | 0 | 0 | 0 |
Working Capital | -6.1M | 0 | -3.8M | -1.6M | -1.4M |
Balance Sheet Composition
Nukkleus Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -8.5M | - | -11.8M | -936.8K | -100.6K |
Depreciation & Amortization | 13.8K | - | 2.7M | 469.3K | 0 |
Stock-Based Compensation | 229.6K | - | 1.9M | 42.1K | 0 |
Working Capital Changes | -5.4M | -1.0M | 3.2M | 2.1M | -3.5M |
Operating Cash Flow | -19.4M | -1.0M | -4.0M | 1.6M | -3.6M |
Investing Activities | |||||
Capital Expenditures | - | - | - | - | - |
Acquisitions | - | - | 0 | -23.3K | 0 |
Investment Purchases | - | - | -35.0K | 0 | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | 132.8K | - | -35.0K | -23.3K | 0 |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 3.0M | - | - | - | - |
Debt Repayment | -183.6K | 0 | - | - | - |
Financing Cash Flow | 3.0M | 0 | - | - | - |
Free Cash Flow | -3.8M | - | 1.6M | 1.2M | 59.3K |
Net Change in Cash | -16.3M | -1.0M | -4.1M | 1.6M | -3.6M |
Cash Flow Trend
Nukkleus Key Financial Ratios
Valuation Ratios
Price to Sales
152.42
Profitability Ratios
Profit Margin
16.89%
Operating Margin
-134.75%
Return on Equity
120.02%
Return on Assets
-864.83%
Financial Health
Current Ratio
0.12
Debt to Equity
-0.04
Beta
-6.04
Per Share Data
EPS (TTM)
$-0.02
Book Value per Share
$-9.94
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
nukkw | 901.4M | - | - | 120.02% | 16.89% | -0.04 |
Salesforce | 235.0B | 38.47 | 3.88 | 10.31% | 16.08% | 19.81 |
Intuit | 200.1B | 58.50 | 9.95 | 17.84% | 19.07% | 0.35 |
Eplus | 1.9B | 17.28 | 1.87 | 11.42% | 5.45% | 12.68 |
Matterport | 1.8B | -6.73 | 4.43 | -55.40% | -151.22% | 0.05 |
Olo | 1.7B | 1,038.00 | 2.44 | -0.13% | -0.28% | 1.80 |
Financial data is updated regularly. All figures are in the company's reporting currency.